During the past decade, Gachon University Gil Medical Center conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 5 clinical trials were completed, i.e. on average, 38.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gachon University Gil Medical Center" #1 sponsor was "Bukwang Pharmaceutical" with 3 trials, followed by "Yonsei University" with 3 trials sponsored, "Chong Kun Dang Pharmaceutical" with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored and "Incyte Corporation" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gachon University Gil Medical Center" #1 collaborator was "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Yonsei University" with 2 trials as a collaborator, "Asan Medical Center" with 1 trials as a collaborator, "Chonnam National University Hospital" with 1 trials as a collaborator and "CliPS Co., Ltd" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Gachon University Gil Medical Center" are "Hypertension" (4 trials), "Hepatitis B" (3 trials), "Multiple Myeloma" (3 trials), "Cardiovascular Diseases" (2 trials) and "Connective Tissue Diseases" (2 trials). Many other conditions were trialed in "Gachon University Gil Medical Center" in a lesser frequency.

Most popular intervention types in "Gachon University Gil Medical Center" are "Drug" (23 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Carboplatin" (3 trials), "Bortezomib" (2 trials), "Clevudine" (2 trials) and "Pembrolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Gachon University Gil Medical Center" are 25 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Gachon University Gil Medical Center". 1 are not yet recruiting, 7 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 11 completed trials in Gachon University Gil Medical Center, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Gachon University Gil Medical Center, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".